What is Immutep Ltd ADR (IMMP) stock price today?

Immutep Ltd ADR (IMMP) currently trades at $0.48 per share. The stock has a market capitalization of $77.30M and a P/E ratio of —x.

Is IMMP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Immutep Ltd ADR has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 2.20.

What is Immutep Ltd ADR's revenue and earnings?

Immutep Ltd ADR has trailing twelve-month (TTM) revenue of $7.92M with profit margins of 0.00%. Earnings per share (EPS) is $-0.41.

Is Immutep Ltd ADR financially healthy?

Immutep Ltd ADR's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 2.20 places it in the grey zone.

IMMP

Immutep Ltd ADR

NASDAQ: IMMP · HEALTHCARE · BIOTECHNOLOGY

$0.48

-2.01% today

Updated 2026-04-29

Market cap

$77.30M

P/E ratio

—

P/S ratio

9.76x

EPS (TTM)

$-0.41

Dividend yield

—

52W range

$0 – $3

Volume

18.7M

Market cap

$77.30M

P/E ratio

—

P/S ratio

9.76x

EPS (TTM)

$-0.41

Dividend yield

—

52W range

$0 – $3

Volume

18.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

8.0

Quality

2.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

2.2

Altman Z-Score

Grey zone

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$1.00

+109.38%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy0 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 91.50% QoQ

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-28.21M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$170369.00	$3.51M	$3.84M	$5.04M	$7.92M
Net income	$-32.21M	$-39.90M	$-42.72M	$-61.43M	$-44.86M
EPS	—	—	—	—	$-0.41
Free cash flow	$-30.25M	$-35.93M	$-35.75M	$-62.10M	$-28.21M
Profit margin	-18,906.51%	-1,138.04%	-1,111.87%	-1,218.02%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMMP	$77.30M	30	8.0	2.5	5.0	8.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Immutep Ltd ADR trades at $0.48. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 2.20, it sits in the grey zone. TTM revenue stands at $7.92M.

Frequently asked questions

What is Immutep Ltd ADR's stock price?

Immutep Ltd ADR (IMMP) trades at $0.48.

Is Immutep Ltd ADR overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Immutep Ltd ADR (IMMP)?

The analyst target price is $1.00, representing +109.4% upside from the current price of $0.48.

What is Immutep Ltd ADR's revenue?

TTM revenue is $7.92M.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

2.20 — grey zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.immutep.com

Quick metrics

P/S ratio9.76x

ROE-61.90%

Beta2.32

50D MA$1.32

200D MA$1.91

Shares out0.15B

Float1.23B

Short ratio—

Avg volume18.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IMMP vs LLY →IMMP vs JNJ →IMMP vs ABBV →Stock screener →